02/26/2026
The Foundation for Sickle Cell Disease Research (FSCDR) is pleased to announce that Dr. Hyeseon Levitsky will present Journavx (Suzetrigine) and Emerging Nonopioid Approaches to Acute Sickle Cell Pain at the Symposium.
Dr. Levitsky is an Assistant Professor at Larkin University College of Pharmacy with more than 25 years of experience in pharmacy practice, including leadership roles as Clinical Pharmacy Coordinator, Investigational Drug Services Coordinator, and Director of Pharmacy.
Her work integrates clinical trials, health-system practice, and pharmacy education, with a focus on patient education and the safe, effective use of approved and investigational therapies in hematology.
This session will focus on practical, evidence-informed approaches to the assessment and management of acute pain in sickle cell disease (SCD), with particular attention to clinical decision-making around newer non-opioid analgesic options such as Journavx (suzetrigine). The presentation will examine real-world challenges encountered in outpatient and transition-of-care settings, including appropriate medication selection, balancing opioid and non-opioid therapies, and interprofessional coordination.
Join us in Fort Lauderdale for this session!
Register Now: https://fscdr2026.eventscribe.net/
